WashU Expert: Soleimani killing likely unlawful

WashU Expert: Soleimani killing likely unlawful

Many questions remain following the Jan. 3 death of Qassem Soleimani and Iran’s potential retaliation. Chief among them: Was the strike legal? “Unless there is much more to the story than meets the eye, the answer seems to be no,” said Leila Sadat, director of the Whitney R. Harris World Law Institute and an expert on international criminal law.
Could 2018 tariff impact been foreseen?

Could 2018 tariff impact been foreseen?

Researchers from Olin Business School explore the complexity of tariffs as a trade tool in a global economy in a new paper. The research also establishes a supply chain model to explain those effects. The model proposes that, in some cases, the effects were foreseeable when accounting for strategic multi-party interactions and competition.
WashU Experts: Arts cuts could prove ‘dire … irreversible’

WashU Experts: Arts cuts could prove ‘dire … irreversible’

While President Trump’s proposed $970 million budget cuts in the arts and humanities account for less than one-tenth of a percent of savings in the administration’s $1.1 trillion federal budget plan, the effect could gut culture and diminish quality of life across the United States if not the world, say experts at Washington University in St. Louis.
Symposium explores the rise of Donald Trump, March 9

Symposium explores the rise of Donald Trump, March 9

“American Democracy and the Rise of Donald Trump” will be the focus as faculty experts in history, political science, sociology, law, economics and psychology gather for a public symposium from 1-4 p.m. Thursday, March 9, in Room 100 of Brown Hall, on the Danforth Campus of Washington University in St. Louis.
WashU Expert: Trump has no clear plan for reducing drug prices

WashU Expert: Trump has no clear plan for reducing drug prices

Despite announcing in his first press conference that he would deal with a pharmaceutical industry “getting away with murder,” President-elect Donald Trump doesn’t seem to have a clear path for how he will reduce drug prices, said Rachel Sachs, associate professor of law and expert on drug regulation and health law.